La colchicine réduit le risque de complications liées à la COVID-19
23 janv. 2021 01h00 HE
|
Institut de Cardiologie de Montréal (ICM)
MONTRÉAL, 23 janv. 2021 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA a fourni des résultats cliniquement convaincants de...
Colchicine reduces the risk of COVID-19-related complications
23 janv. 2021 01h00 HE
|
Montreal Heart Institute
MONTREAL, Jan. 23, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy...
La colchicine réduit le risque de complications liées à la COVID-19
22 janv. 2021 22h58 HE
|
Institut de Cardiologie de Montréal (ICM)
MONTRÉAL, 22 janv. 2021 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA a fourni des résultats cliniquement convaincants de...
Colchicine reduces the risk of COVID-19-related complications
22 janv. 2021 22h58 HE
|
Montreal Heart Institute
MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy...
New data supports development of colchicine for the prevention of acute respiratory distress syndrome
03 déc. 2020 12h00 HE
|
Montreal Heart Institute
MONTREAL, Dec. 03, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) has announced that colchicine, a widely available low-cost drug, reduces acute lung injury (ALI), acute respiratory...
La colchicine se révèle prometteuse pour traiter à domicile les patients atteints de la COVID-19
28 nov. 2020 19h49 HE
|
Institut de Cardiologie de Montréal (ICM)
Montréal, 28 nov. 2020 (GLOBE NEWSWIRE) -- L’Institut de Cardiologie de Montréal (ICM) annonce aujourd’hui que l’étude clinique COLCORONA continuera de recruter des patients adultes...
Colchicine shows promise as a treatment for at-home COVID-19 patients
28 nov. 2020 19h49 HE
|
Montreal Heart Institute
MONTREAL, Nov. 28, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with...
L'Institut de Cardiologie de Montréal (ICM) annonce que l'étude clinique COLCORONA des patients atteints de la COVID-19 a passé le test de la futilité
26 juin 2020 21h53 HE
|
Institut de Cardiologie de Montréal (ICM)
MONTRÉAL, 26 juin 2020 (GLOBE NEWSWIRE) -- L'Institut de Cardiologie de Montréal annonce aujourd'hui que l’étude clinique COLCORONA continuera de recruter des patients adultes non-hospitalisés...
Montreal Heart Institute announces COLCORONA trial in patients with COVID-19 passes futility test in interim analysis
26 juin 2020 21h53 HE
|
Montreal Heart Institute
MONTREAL, June 26, 2020 (GLOBE NEWSWIRE) -- Montreal Heart Institute today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as...
FDA and Health Canada Approve Thermedical’s Degassed Saline to Help Reduce Risk of Stroke
16 juin 2020 09h09 HE
|
Montreal Heart Institute
MONTREAL and WALTHAM, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) and Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, today...